UTHR · UNITED THERAPEUTICS Corp
$499.73
-1.54 (-0.31%)
At close · Aug 14
Market Cap
$21.43B
Shares
42.89M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding UTHR
712 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | — | 1,425,491 | $845,287,653 | 0.80% | Long | 2026-03-31 | |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 1,392,532 | $825,743,625 | 0.04% | Long | 2026-03-31 | |
| VANGUARD SMALL-CAP INDEX FUND | — | 1,010,571 | $599,248,392 | 0.36% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE FUND | — | 822,896 | $470,161,630 | 1.28% | Long | 2026-04-30 | |
| VANGUARD SMALL-CAP VALUE INDEX FUND | — | 643,525 | $381,597,455 | 0.63% | Long | 2026-03-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 480,606 | $284,989,746 | 0.35% | Long | 2026-03-31 | |
| Invesco S&P MidCap Quality ETF | — | 361,146 | $206,340,767 | 3.98% | Long | 2026-04-30 | |
| State Street SPDR S&P MidCap 400SM ETF Trust | MDY | 324,529 | $192,439,206 | 0.79% | Long | 2026-03-31 | |
| iShares Biotechnology ETF | — | 315,509 | $187,090,527 | 2.30% | Long | 2026-03-31 | |
| VANGUARD U.S. GROWTH FUND | — | 304,130 | $169,345,667 | 0.36% | Long | 2026-05-31 | |
| iShares S&P Mid-Cap 400 Growth ETF | — | 261,785 | $155,233,269 | 1.57% | Long | 2026-03-31 | |
| FULLERTHALER BEHAVIORAL SMALL CAP EQUITY | — | 261,071 | $154,809,882 | 1.38% | Long | 2026-03-31 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 246,943 | $146,432,260 | 1.34% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | — | 210,359 | $124,738,680 | 0.80% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 221,883 | $123,548,892 | 0.29% | Long | 2026-05-31 | |
| Strategic Advisers U.S. Total Stock Fund | — | 197,884 | $110,185,769 | 0.11% | Long | 2026-05-31 | |
| First Trust NYSE Arca Biotechnology Index Fund | — | 166,849 | $98,938,120 | 4.36% | Long | 2026-03-31 | |
| iShares Russell Mid-Cap ETF | — | 162,241 | $96,205,668 | 0.20% | Long | 2026-03-31 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | — | 155,530 | $92,226,179 | 1.24% | Long | 2026-03-31 | |
| Fidelity Mid Cap Index Fund | — | 157,079 | $89,747,087 | 0.18% | Long | 2026-04-30 | |
| Franklin Dynatech Fund | — | 150,000 | $88,947,000 | 0.36% | Long | 2026-03-31 | |
| Fidelity SAI U.S. Quality Index Fund | — | 131,501 | $75,133,096 | 0.26% | Long | 2026-04-30 | |
| Pacer US Cash Cows 100 ETF | — | 130,190 | $74,384,057 | 0.41% | Long | 2026-04-30 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | — | 132,226 | $73,626,081 | 0.03% | Long | 2026-05-31 | |
| Janus Henderson Global Life Sciences Fund | — | 116,721 | $69,213,219 | 1.33% | Long | 2026-03-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 122,899 | $68,432,621 | 0.36% | Long | 2026-05-31 | |
| Schwab U.S. Mid-Cap ETF | — | 116,428 | $64,829,439 | 0.44% | Long | 2026-05-31 | |
| iShares Russell 1000 Value ETF | — | 97,116 | $57,587,846 | 0.08% | Long | 2026-03-31 | |
| Pacer US Large Cap Cash Cows Growth Leaders ETF | — | 95,745 | $54,703,906 | 2.52% | Long | 2026-04-30 | |
| Lord Abbett Fundamental Equity Fund | — | 91,588 | $52,328,804 | 2.37% | Long | 2026-04-30 | |
| HARTFORD CORE EQUITY FUND | — | 90,258 | $51,568,908 | 0.45% | Long | 2026-04-30 | |
| iShares MSCI USA Min Vol Factor ETF | — | 85,283 | $48,726,442 | 0.21% | Long | 2026-04-30 | |
| Select Biotechnology Portfolio | — | 82,591 | $45,988,321 | 0.87% | Long | 2026-05-31 | |
| Janus Henderson Research Fund | — | 76,641 | $45,446,580 | 0.18% | Long | 2026-03-31 | |
| Fidelity Total Market Index Fund | — | 81,315 | $45,277,818 | 0.03% | Long | 2026-05-31 | |
| iShares MSCI USA Quality Factor ETF | — | 77,857 | $44,483,597 | 0.09% | Long | 2026-04-30 | |
| State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF | — | 65,450 | $38,810,541 | 1.57% | Long | 2026-03-31 | |
| VIP Mid Cap Portfolio | — | 65,400 | $38,780,892 | 0.49% | Long | 2026-03-31 | |
| VANGUARD S&P MID-CAP 400 INDEX FUND | — | 68,705 | $38,256,318 | 0.68% | Long | 2026-05-31 | |
| Fidelity Series Total Market Index Fund | — | 65,688 | $36,576,392 | 0.03% | Long | 2026-05-31 | |
| iShares Russell Mid-Cap Value ETF | — | 61,017 | $36,181,861 | 0.26% | Long | 2026-03-31 | |
| THE U.S. LARGE CAP VALUE SERIES | — | 62,442 | $35,676,237 | 0.12% | Long | 2026-04-30 | |
| Dimensional U.S. Core Equity 2 ETF | — | 62,218 | $35,548,254 | 0.08% | Long | 2026-04-30 | |
| Fidelity Mid-Cap Stock Fund | — | 61,483 | $35,128,312 | 0.40% | Long | 2026-04-30 | |
| LORD ABBETT MID CAP STOCK FUND INC | — | 56,726 | $33,637,383 | 3.10% | Long | 2026-03-31 | |
| U.S. CORE EQUITY 1 PORTFOLIO | — | 56,215 | $32,118,440 | 0.08% | Long | 2026-04-30 | |
| iShares Core S&P Total U.S. Stock Market ETF | — | 54,127 | $32,096,228 | 0.04% | Long | 2026-03-31 | |
| First Trust Growth Strength ETF | — | 53,047 | $31,455,810 | 2.71% | Long | 2026-03-31 | |
| Fidelity Contrafund | — | 52,989 | $31,421,417 | 0.02% | Long | 2026-03-31 | |
| BlackRock Health Sciences Opportunities Portfolio | — | 55,689 | $31,008,749 | 0.53% | Long | 2026-05-29 |
Showing 1–50 of 712 positions
Key facts
CIK
1082554
CUSIP
91307C102
13F (30d)
806 filings
786 filers
Visit website
Investor relations